SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001437749-22-008264
Filing Date
2022-04-05
Accepted
2022-04-05 06:03:39
Documents
8
Period of Report
2022-05-18

Document Format Files

Seq Description Document Type Size
1 FORM DEF 14A dmtp20220327_def14a.htm DEF 14A 993775
2 a01.jpg GRAPHIC 10577
3 a2.jpg GRAPHIC 4195
4 a03.jpg GRAPHIC 1509
5 dmtp20220327_def14aimg005.jpg GRAPHIC 1790
6 image01.jpg GRAPHIC 49133
7 proxy01.jpg GRAPHIC 179618
8 proxy02.jpg GRAPHIC 213558
  Complete submission text file 0001437749-22-008264.txt   1629425
Mailing Address TWO CARLSON PARKWAY SUITE 260 MINNEAPOLIS MN 55447
Business Address TWO CARLSON PARKWAY SUITE 260 MINNEAPOLIS MN 55447 (763) 496-5454
DiaMedica Therapeutics Inc. (Filer) CIK: 0001401040 (see all company filings)

IRS No.: 000000000 | State of Incorp.: Z4 | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-36291 | Film No.: 22805100
SIC: 2834 Pharmaceutical Preparations